Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
VMF
0
FDF
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. 17 Desoxymethasone
2. 17-desoxymethasone
3. A 41304
4. A-41304
5. A41304
6. Deoxydexamethasone
7. Desoxi
8. Desoxymethasone
9. Flubason
10. Ibaril
11. Stiedex
12. Topicort
13. Topicorte
14. Topisolon
1. 382-67-2
2. Desoxymethasone
3. Topicort
4. Desoximetasona
5. Desoximetasonum
6. Topicort Lp
7. Desoxymetasone
8. Hoe-304
9. Hoe 304
10. A-41-304
11. Deoxymethasone
12. 9-fluoro-11beta,21-dihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione
13. R-2113
14. (8s,9r,10s,11s,13s,14s,16r,17s)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,11,12,14,15,16,17-octahydro-6h-cyclopenta[a]phenanthren-3-one
15. Chebi:691037
16. Dexamethasone Impurity F
17. R 2113
18. 4e07gxb7au
19. Esperson
20. Mls000028654
21. 17-deoxymethansone
22. 17-desoximethasone
23. A-41304
24. 9alpha-fluoro-16alpha-methyl-delta(1)-corticosterone
25. Nsc-759189
26. (8s,9r,10s,11s,13s,14s,16r,17s)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3h-cyclopenta[a]phenanthren-3-one
27. 140218-14-0
28. Ncgc00023648-03
29. Flubason
30. J83.644c
31. Smr000058856
32. Stiedex
33. Ibaril
34. (11beta,16alpha)-9-fluoro-11,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione
35. Dsstox_cid_25647
36. Dsstox_rid_81025
37. Dsstox_gsid_45647
38. Desossimetasone
39. A 41304
40. Topicort (tn)
41. Cas-382-67-2
42. Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-, Labeled With Tritium, (11beta,16alpha)-
43. Desossimetasone [dcit]
44. A 41-304
45. Desoximetasone (usp/inn)
46. Unii-4e07gxb7au
47. Desoximetasonum [inn-latin]
48. Desoximetasona [inn-spanish]
49. Einecs 206-845-3
50. Desoximetasone [usan:usp:inn:ban]
51. Brn 2228097
52. Opera_id_52
53. Desoximetasone [mi]
54. Schembl4214
55. Chembl1766
56. Desoximetasone [inn]
57. Desoximetasone [jan]
58. Desoximetasone [usan]
59. Mls001076073
60. Mls001424230
61. Desoximetasone [vandf]
62. Desoximetasone [mart.]
63. Gtpl7067
64. Desoximetasone [usp-rs]
65. Desoximetasone [who-dd]
66. Dtxsid3045647
67. 9-fluoro-11.beta.,21-dihydroxy-16.alpha.-methylpregna-1,4-diene-3,20-dione
68. Hms2052c15
69. Hms2236h07
70. Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-, (11.beta.,16.alpha.)-
71. Zinc4212854
72. Desoximetasone [orange Book]
73. Tox21_110889
74. Bdbm50103622
75. Desoximetasone [usp Impurity]
76. Mfcd00083301
77. S5685
78. Desoximetasone [usp Monograph]
79. 9-fluoro-11-beta,21-dihydroxy-16-alpha-methylpregna-1,4-diene-3,20-dione
80. Akos030254657
81. Tox21_110889_1
82. Ccg-101120
83. Db00547
84. Nc00370
85. Nsc 759189
86. Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-, (11beta,16alpha)-
87. Ncgc00023648-04
88. As-15787
89. Hy-17570
90. D5515
91. Dexamethasone Impurity F [ep Impurity]
92. D03697
93. T72402
94. 382d672
95. Q385370
96. Q-200938
97. 9alpha-fluoro-11beta,21-dihydroxy-16alpha-methyl-1.4-pregnadiene-3,20-dione
98. (1r,2s,10s,11s,13r,14s,15s,17s)-1-fluoro-17-hydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-5-one
Molecular Weight | 376.5 g/mol |
---|---|
Molecular Formula | C22H29FO4 |
XLogP3 | 2.3 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 2 |
Exact Mass | 376.20498756 g/mol |
Monoisotopic Mass | 376.20498756 g/mol |
Topological Polar Surface Area | 74.6 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 757 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 8 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 4 | |
---|---|
Drug Name | Desoximetasone |
Drug Label | Topicort (desoximetasone cream USP) 0.05%, Topicort (desoximetasone cream USP) 0.25%, and Topicort (desoximetasone gel USP) 0.05% contain the active synthetic corticosteroid desoximetasone. The topical corticosteroids constitute a class of prim... |
Active Ingredient | Desoximetasone |
Dosage Form | Gel; Ointment; Cream |
Route | Topical |
Strength | 0.05%; 0.25% |
Market Status | Prescription |
Company | Glenmark Generics; Fougera Pharms; Versapharm; Perrigo New York |
2 of 4 | |
---|---|
Drug Name | Topicort |
PubMed Health | Desoximetasone (On the skin) |
Drug Classes | Anti-Inflammatory, Corticosteroid, Strong, Dermatological Agent |
Drug Label | Topicort (desoximetasone cream USP) 0.05%, Topicort (desoximetasone cream USP) 0.25%, and Topicort (desoximetasone gel USP) 0.05% contain the active synthetic corticosteroid desoximetasone. The topical corticosteroids constitute a class of prim... |
Active Ingredient | Desoximetasone |
Dosage Form | Ointment; Cream; Spray; Gel |
Route | Topical |
Strength | 0.05%; 0.25% |
Market Status | Prescription |
Company | Taro; Taro Pharms North |
3 of 4 | |
---|---|
Drug Name | Desoximetasone |
Drug Label | Topicort (desoximetasone cream USP) 0.05%, Topicort (desoximetasone cream USP) 0.25%, and Topicort (desoximetasone gel USP) 0.05% contain the active synthetic corticosteroid desoximetasone. The topical corticosteroids constitute a class of prim... |
Active Ingredient | Desoximetasone |
Dosage Form | Gel; Ointment; Cream |
Route | Topical |
Strength | 0.05%; 0.25% |
Market Status | Prescription |
Company | Glenmark Generics; Fougera Pharms; Versapharm; Perrigo New York |
4 of 4 | |
---|---|
Drug Name | Topicort |
PubMed Health | Desoximetasone (On the skin) |
Drug Classes | Anti-Inflammatory, Corticosteroid, Strong, Dermatological Agent |
Drug Label | Topicort (desoximetasone cream USP) 0.05%, Topicort (desoximetasone cream USP) 0.25%, and Topicort (desoximetasone gel USP) 0.05% contain the active synthetic corticosteroid desoximetasone. The topical corticosteroids constitute a class of prim... |
Active Ingredient | Desoximetasone |
Dosage Form | Ointment; Cream; Spray; Gel |
Route | Topical |
Strength | 0.05%; 0.25% |
Market Status | Prescription |
Company | Taro; Taro Pharms North |
For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
FDA Label
Like other topical corticosteroids, desoximetasone has anti-inflammatory, antipruritic, and vasoconstrictive properties. Once absorbed through the skin, topical corticosteroids are handled through pharmacokinetic pathways similar to systemically administered corticosteroids. Desoximetasone is a potent topical corticosteroid that should not be used with occlusive dressings. It is recommended that treatment should be limited to 2 consecutive weeks and therapy should be discontinued when adequate results have been achieved.
Anti-Inflammatory Agents
Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)
Glucocorticoids
A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. (See all compounds classified as Glucocorticoids.)
D - Dermatologicals
D07 - Corticosteroids, dermatological preparations
D07A - Corticosteroids, plain
D07AC - Corticosteroids, potent (group iii)
D07AC03 - Desoximetasone
D - Dermatologicals
D07 - Corticosteroids, dermatological preparations
D07X - Corticosteroids, other combinations
D07XC - Corticosteroids, potent, other combinations
D07XC02 - Desoximetasone
Absorption
Topical corticosteroids can be absorbed from intact healthy skin. The extent of percutaneous absorption of topical corticosteroids is determined by many factors, including the vehicle and the integrity of the epidermal barrier. Occlusion, inflammation and/or other disease processes in the skin may also increase percutaneous absorption.
Route of Elimination
Corticosteroids are bound to plasma proteins in varying degrees, are metabolized primarily in the liver and excreted by the kidneys. Some of the topical corticosteroids and their metabolites are also excreted into the bile.Pharmacokinetic studies in men with Desoximetasone Cream USP, 0.25% with tagged desoximetasone showed a total of 5.2% 2.9% excretion in urine (4.1% 2.3%) and feces (1.1% 0.6%)
Metabolized, primarily in the liver, and then excreted by the kidneys.
The half-life of the material was 15 ± 2 hours (for urine) and 17 ± 2 hours (for feces) between the third and fifth trial day.
The precise mechanism of the antiinflammatory activity of topical steroids in the treatment of steroid-responsive dermatoses, in general, is uncertain. However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. This is achieved first by the drug binding to the glucocorticoid receptors which then translocates into the nucleus and binds to DNA causing various activations and repressions of genes. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2.
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Desoximetasone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Desoximetasone, including repackagers and relabelers. The FDA regulates Desoximetasone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Desoximetasone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Desoximetasone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Desoximetasone supplier is an individual or a company that provides Desoximetasone active pharmaceutical ingredient (API) or Desoximetasone finished formulations upon request. The Desoximetasone suppliers may include Desoximetasone API manufacturers, exporters, distributors and traders.
click here to find a list of Desoximetasone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Desoximetasone DMF (Drug Master File) is a document detailing the whole manufacturing process of Desoximetasone active pharmaceutical ingredient (API) in detail. Different forms of Desoximetasone DMFs exist exist since differing nations have different regulations, such as Desoximetasone USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Desoximetasone DMF submitted to regulatory agencies in the US is known as a USDMF. Desoximetasone USDMF includes data on Desoximetasone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Desoximetasone USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Desoximetasone suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Desoximetasone Drug Master File in Korea (Desoximetasone KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Desoximetasone. The MFDS reviews the Desoximetasone KDMF as part of the drug registration process and uses the information provided in the Desoximetasone KDMF to evaluate the safety and efficacy of the drug.
After submitting a Desoximetasone KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Desoximetasone API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Desoximetasone suppliers with KDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Desoximetasone as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Desoximetasone API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Desoximetasone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Desoximetasone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Desoximetasone NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Desoximetasone suppliers with NDC on PharmaCompass.
Desoximetasone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Desoximetasone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Desoximetasone GMP manufacturer or Desoximetasone GMP API supplier for your needs.
A Desoximetasone CoA (Certificate of Analysis) is a formal document that attests to Desoximetasone's compliance with Desoximetasone specifications and serves as a tool for batch-level quality control.
Desoximetasone CoA mostly includes findings from lab analyses of a specific batch. For each Desoximetasone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Desoximetasone may be tested according to a variety of international standards, such as European Pharmacopoeia (Desoximetasone EP), Desoximetasone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Desoximetasone USP).
LOOKING FOR A SUPPLIER?